ScoreWhy is Welcure Drugs & Pharmaceuticals Ltd ?
1
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 1.82%
- Poor long term growth as Operating profit has grown by an annual rate 13.46% of over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 9.73 times
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Welcure Drugs for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Welcure Drugs
-24.27%
-0.39
65.27%
Sensex
4.83%
0.41
11.83%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
91.10%
EBIT Growth (5y)
13.46%
EBIT to Interest (avg)
8.99
Debt to EBITDA (avg)
123.20
Net Debt to Equity (avg)
1.20
Sales to Capital Employed (avg)
0.11
Tax Ratio
23.82%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
-3.09%
ROE (avg)
4.93%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
2
Industry P/E
34
Price to Book Value
0.64
EV to EBIT
4.36
EV to EBITDA
4.36
EV to Capital Employed
0.84
EV to Sales
0.49
PEG Ratio
0.01
Dividend Yield
NA
ROCE (Latest)
0.98%
ROE (Latest)
33.54%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend24What is working for the Company
NET SALES(Latest six months)
Higher at Rs 365.53 cr
PBT LESS OI(Q)
At Rs 11.36 cr has Grown at 34.8% (vs previous 4Q average
PAT(Q)
At Rs 8.50 cr has Grown at 22.7% (vs previous 4Q average
0What is not working for the Company
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...
Here's what is working for Welcure Drugs
Net Sales - Latest six months
At Rs 365.53 cr has Grown at 1,388.92%
Year on Year (YoY)MOJO Watch
Sales trend is very positive
Net Sales (Rs Cr)
Net Sales - Latest six months
Higher at Rs 365.53 cr
than preceding 12 month period ended Sep 2025 of Rs 46.64 crMOJO Watch
In the half year the company has already crossed sales of the previous twelve months
Net Sales (Rs Cr)
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 11.36 cr has Grown at 34.8% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 8.43 CrMOJO Watch
Near term PBT trend is positive
PBT less Other Income (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 8.50 cr has Grown at 22.7% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 6.93 CrMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
